Title 405
Office of the Secretary of Family and Social Services |
| DIN: 20101006-IR-405100250NRA
(
HTML
- PDF
)
|
| Type: NR
Posted: 10/06/2010
LSA Doc #10-250
Title 405
|
|
http://www.in.gov/legislative/iac/20100915-IR-405100250FRA.xml.html
The rates are available at the offices of the Family and Social Services Administration, Office of Medicaid Policy and Planning. Ra... |
|
| DIN: 20100915-IR-405100250FRA
(
HTML
- PDF
)
|
| Type: FR
Posted: 09/15/2010
LSA Doc #10-250
Title 405
|
|
Amends 405 IAC 1-11.5-2 to modify Medicaid reimbursement for physician-administered drugs, which shall not apply to parenteral nutrition and blood factor products. Effective 30 days after filing with... |
|
| DIN: 20100819-IR-405100250AFA
(
HTML
- PDF
)
|
| Type: AF
Posted: 08/19/2010
LSA Doc #10-250
Title 405
|
| Publisher's receipt for LSA Document #10-250(F) |
|
| DIN: 20100818-IR-405100250NAA
(
HTML
- PDF
)
|
| Type: NA
Posted: 08/18/2010
LSA Doc #10-250
Title 405
|
|
Notice of Rule Adoption
LSA Document #10-250
This notice is published in accordance with IC 12-8-3-4.4. Under IC 4-22-2-29, LSA Document #10-250, posted at 20100714-IR-405100250PRA, was adopted by t... |
|
| DIN: 20100714-IR-405100250EIA
(
HTML
- PDF
)
|
| Type: EI
Posted: 07/14/2010
LSA Doc #10-250
Title 405
|
|
Economic Impact Statement
LSA Document #10-250
|
|
| DIN: 20100714-IR-405100250PHA
(
HTML
- PDF
)
|
| Type: PH
Posted: 07/14/2010
LSA Doc #10-250
Title 405
|
|
Notice of Public Hearing
LSA Document #10-250
|
|
| DIN: 20100714-IR-405100250PRA
(
HTML
- PDF
)
|
| Type: PR
Posted: 07/14/2010
LSA Doc #10-250
Title 405
|
|
Amends 405 IAC 1-11.5-2 to modify Medicaid reimbursement for physician-administered drugs, which shall not apply to parenteral nutrition and blood factor products. Effective 30 days after filing with... |
|
| DIN: 20100505-IR-405100250NIA
(
HTML
- PDF
)
|
| Type: NI
Posted: 05/05/2010
LSA Doc #10-250
Title 405
|
|
OVERVIEW: Amends 405 IAC 1-11.5-2 to modify Medicaid reimbursement for physician-administered drugs. This provision shall not apply to parenteral nutrition and blood factor products. Statutory author... |
|